Loading…
Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor
Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca release from intac...
Saved in:
Published in: | Molecular pharmacology 2019-09, Vol.96 (3), p.401-407 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883 |
---|---|
cites | cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883 |
container_end_page | 407 |
container_issue | 3 |
container_start_page | 401 |
container_title | Molecular pharmacology |
container_volume | 96 |
creator | Diszházi, Gyula Magyar, Zsuzsanna Édua Mótyán, János András Csernoch, László Jóna, István Nánási, Péter Pál Almássy, János |
description | Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca
release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg
was demonstrated to be the essential factor for dantrolene to inhibit Ca
release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca
release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca
release experiments demonstrated that the effect of dantrolene and Mg
was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10
M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg
and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg
-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR. |
doi_str_mv | 10.1124/mol.119.116475 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_mol_119_116475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>31337666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</originalsourceid><addsrcrecordid>eNo9kM1Lw0AQxRdRbK1ePcreJXVnN_uRY6lVCxVFIngLu5uJjbRJ3KSH_veuVj0M82B-b-A9Qi6BTQF4erNtN1FkcVSq5REZg-SQMAA4JmPGuEpMJt9G5KzvPxiDVBp2SkYChNBKqTGZ39pmCO0GG6Qv-LmrA_b08Z3ya2qbks7yZ5q3dNmsa1cPdFhHam-btqx_eI_d0IZzclLZTY8Xv3tCXu8W-fwhWT3dL-ezVeKBaZVoXmqhnasg414ap8BU2nCPHBFZ6dB4LZWq4j0D5zPURionLbNMgDJGTMj08NeHtu8DVkUX6q0N-wJY8d1GEduIIisObUTD1cHQ7dwWy3_8L774Ah3mWWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><source>Free Full-Text Journals in Chemistry</source><creator>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</creator><creatorcontrib>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</creatorcontrib><description>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca
release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg
was demonstrated to be the essential factor for dantrolene to inhibit Ca
release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca
release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca
release experiments demonstrated that the effect of dantrolene and Mg
was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10
M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg
and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg
-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.119.116475</identifier><identifier>PMID: 31337666</identifier><language>eng</language><publisher>United States</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Binding Sites ; Calcium - metabolism ; Dantrolene - chemistry ; Dantrolene - pharmacology ; Magnesium - metabolism ; Male ; Models, Molecular ; Molecular Conformation ; Muscle, Skeletal - metabolism ; Protein Binding ; Rabbits ; Ryanodine Receptor Calcium Release Channel - chemistry ; Ryanodine Receptor Calcium Release Channel - metabolism</subject><ispartof>Molecular pharmacology, 2019-09, Vol.96 (3), p.401-407</ispartof><rights>Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</citedby><cites>FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31337666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diszházi, Gyula</creatorcontrib><creatorcontrib>Magyar, Zsuzsanna Édua</creatorcontrib><creatorcontrib>Mótyán, János András</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Jóna, István</creatorcontrib><creatorcontrib>Nánási, Péter Pál</creatorcontrib><creatorcontrib>Almássy, János</creatorcontrib><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca
release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg
was demonstrated to be the essential factor for dantrolene to inhibit Ca
release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca
release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca
release experiments demonstrated that the effect of dantrolene and Mg
was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10
M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg
and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg
-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Calcium - metabolism</subject><subject>Dantrolene - chemistry</subject><subject>Dantrolene - pharmacology</subject><subject>Magnesium - metabolism</subject><subject>Male</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Protein Binding</subject><subject>Rabbits</subject><subject>Ryanodine Receptor Calcium Release Channel - chemistry</subject><subject>Ryanodine Receptor Calcium Release Channel - metabolism</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kM1Lw0AQxRdRbK1ePcreJXVnN_uRY6lVCxVFIngLu5uJjbRJ3KSH_veuVj0M82B-b-A9Qi6BTQF4erNtN1FkcVSq5REZg-SQMAA4JmPGuEpMJt9G5KzvPxiDVBp2SkYChNBKqTGZ39pmCO0GG6Qv-LmrA_b08Z3ya2qbks7yZ5q3dNmsa1cPdFhHam-btqx_eI_d0IZzclLZTY8Xv3tCXu8W-fwhWT3dL-ezVeKBaZVoXmqhnasg414ap8BU2nCPHBFZ6dB4LZWq4j0D5zPURionLbNMgDJGTMj08NeHtu8DVkUX6q0N-wJY8d1GEduIIisObUTD1cHQ7dwWy3_8L774Ah3mWWQ</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Diszházi, Gyula</creator><creator>Magyar, Zsuzsanna Édua</creator><creator>Mótyán, János András</creator><creator>Csernoch, László</creator><creator>Jóna, István</creator><creator>Nánási, Péter Pál</creator><creator>Almássy, János</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201909</creationdate><title>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</title><author>Diszházi, Gyula ; Magyar, Zsuzsanna Édua ; Mótyán, János András ; Csernoch, László ; Jóna, István ; Nánási, Péter Pál ; Almássy, János</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Calcium - metabolism</topic><topic>Dantrolene - chemistry</topic><topic>Dantrolene - pharmacology</topic><topic>Magnesium - metabolism</topic><topic>Male</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Protein Binding</topic><topic>Rabbits</topic><topic>Ryanodine Receptor Calcium Release Channel - chemistry</topic><topic>Ryanodine Receptor Calcium Release Channel - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diszházi, Gyula</creatorcontrib><creatorcontrib>Magyar, Zsuzsanna Édua</creatorcontrib><creatorcontrib>Mótyán, János András</creatorcontrib><creatorcontrib>Csernoch, László</creatorcontrib><creatorcontrib>Jóna, István</creatorcontrib><creatorcontrib>Nánási, Péter Pál</creatorcontrib><creatorcontrib>Almássy, János</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diszházi, Gyula</au><au>Magyar, Zsuzsanna Édua</au><au>Mótyán, János András</au><au>Csernoch, László</au><au>Jóna, István</au><au>Nánási, Péter Pál</au><au>Almássy, János</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2019-09</date><risdate>2019</risdate><volume>96</volume><issue>3</issue><spage>401</spage><epage>407</epage><pages>401-407</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>Dantrolene is a ryanodine receptor (RyR) inhibitor, which is used to relax muscles in malignant hyperthermia syndrome. Although dantrolene binds to the RyR protein, its mechanism of action is unknown, mainly because of the controversial results showing that dantrolene inhibited Ca
release from intact fibers and sarcoplasmic reticulum (SR) vesicles, but failed to inhibit single RyR channel currents in bilayers. Accordingly, it was concluded that an important factor for dantrolene's action was lost during the purification procedure of RyR. Recently, Mg
was demonstrated to be the essential factor for dantrolene to inhibit Ca
release in skinned muscle fibers. The aim of the present study was to confirm these results in Ca
release and bilayer experiments, using SR vesicles and solubilized channels, respectively. Our Ca
release experiments demonstrated that the effect of dantrolene and Mg
was cooperative and that ATP enhanced the inhibiting effect of dantrolene. Namely, 10
M dantrolene reduced RyR channel open probability by ∼50% in the presence of 3 mM free Mg
and 1 mM ATP, whereas channel activity further decreased to ∼20% of control when [ATP] was increased to 2 mM. Our data provide important complementary information that supports the direct, Mg
-dependent mechanism of dantrolene's action and suggests that dantrolene also requires ATP to inhibit RyR.</abstract><cop>United States</cop><pmid>31337666</pmid><doi>10.1124/mol.119.116475</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0026-895X |
ispartof | Molecular pharmacology, 2019-09, Vol.96 (3), p.401-407 |
issn | 0026-895X 1521-0111 |
language | eng |
recordid | cdi_crossref_primary_10_1124_mol_119_116475 |
source | Free Full-Text Journals in Chemistry |
subjects | Adenosine Triphosphate - metabolism Animals Binding Sites Calcium - metabolism Dantrolene - chemistry Dantrolene - pharmacology Magnesium - metabolism Male Models, Molecular Molecular Conformation Muscle, Skeletal - metabolism Protein Binding Rabbits Ryanodine Receptor Calcium Release Channel - chemistry Ryanodine Receptor Calcium Release Channel - metabolism |
title | Dantrolene Requires Mg 2+ and ATP To Inhibit the Ryanodine Receptor |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dantrolene%20Requires%20Mg%202+%20and%20ATP%20To%20Inhibit%20the%20Ryanodine%20Receptor&rft.jtitle=Molecular%20pharmacology&rft.au=Diszh%C3%A1zi,%20Gyula&rft.date=2019-09&rft.volume=96&rft.issue=3&rft.spage=401&rft.epage=407&rft.pages=401-407&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.119.116475&rft_dat=%3Cpubmed_cross%3E31337666%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1076-72d737bbf192c58b618f782ce2eee0dbe8c7566ff1991bc9e7856b5a0a0316883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/31337666&rfr_iscdi=true |